Evidence map›Paper›PMID 38032577›Full record

ArticleJACC. Clinical electrophysiology2024

Pericarditis After Catheter Ablation for Atrial Fibrillation: Predictors and Outcomes.

Ritu Yadav, Danish Iltaf Satti, Jui Malwankar, Carolina Lopez-Silva, Lillian Xu, Elana Liebow-Feeser, Tauseef Akhtar, Joseph E Marine, Ronald Berger, Hugh Calkins and 1 more

Open access · greenAbstract read
In one paragraph

Article in JACC. Clinical electrophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 4 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 4 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pulsed field ablation for the interventional treatment of atrial fibrillation: a scientific statement of the European Heart Rhythm Association of the European Society of Cardiology, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Guideline
  2. Pooled it
  3. Ethanol infusion of the vein of marshall-based strategies for persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  4. Pooled it
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Incidence of acute pericarditis after pulsed-field ablation for the treatment of atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ritu YadavDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Danish Iltaf SattiDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Jui MalwankarDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Carolina Lopez-SilvaDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Lillian XuDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Elana Liebow-FeeserDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Tauseef AkhtarDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Joseph E MarineDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Ronald BergerDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Hugh CalkinsDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
David SpraggDivision of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA. Electronic address: dspragg1@jhmi.edu.
Johns Hopkins Hospital · US

Funding

Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
NIGMS NIH HHS T32 GM136577
6 · The paper itself

Abstract

backgroundCatheter ablation is a mainstay of atrial fibrillation (AF) treatment. Acute pericarditis after ablation is 1 of the frequently observed complications. There is a significant lack of data on the incidence and predictors of postablation pericarditis.

objectivesThis study examines the incidence, characteristics, and predictors of pericarditis after AF ablation.

methodsPatients undergoing AF ablation from January 1, 2016, to March 31, 2022, at Johns Hopkins were prospectively enrolled in an AF ablation registry. A clinical diagnosis of acute pericarditis was established in accordance with 2015 European Society of Cardiology guidelines by the presence of at least 2 of the following characteristics: pleuritic chest pain, friction rub, typical electrocardiographic changes, or pericardial effusion within 3 months after the ablation procedure.

resultsOf 1,540 patients who underwent AF ablation, 57 patients (3.7%) developed acute pericarditis. Baseline clinical characteristics including age, sex, and body mass index were comparable between the pericarditis and nonpericarditis groups. The median time to symptom onset was 1 day. Electrocardiographic changes were observed in 34 (59.6%) patients, pericardial effusion developed in 7 (12%) patients, and the mean duration of medical treatment was 7 days (25th-75th percentile: 3-14 days). Most pericarditis cases were treated medically with disease-specific nonsteroidal anti-inflammatory drugs (100%) and colchicine (81%). Effusion with tamponade necessitating pericardiocentesis was observed in 4 (7%) patients. Radiofrequency (RF) ablation was performed in 869 (58.6%) patients in the nonpericarditis group and 39 (68.4%) patients with pericarditis; cryoballoon ablation was performed in 486 (32.8%) patients in the nonpericarditis group and 11 (19.3%) patients with pericarditis. Multivariable logistic regression analysis identified RF ablation (OR: 2.09; 95% CI: 1.07-4.08; P = 0.03) as an independent predictor of acute pericarditis after AF ablation, whereas age per unit increase was associated with a decreased risk (OR: 0.97; 95% CI: 0.95-0.995; P = 0.02).

conclusionsThe incidence of acute pericarditis after catheter ablation in our study population was 3.7%. RF ablation and younger age were independent risk factors for postablation acute pericarditis.

Indexed as

Atrial FibrillationCatheter AblationCryosurgeryPericardial EffusionPericarditisHumansTreatment Outcomeatrial fibrillationcatheter ablationcryoballoon ablationpericardial effusionpericarditisradiofrequency ablation

Identifiers

PMID38032577
PMCPMC12103817
OpenAlexW4389121534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.